DBV Technologies
Develops epicutaneous immunotherapy (EPIT) patch technology for food allergies.
DBV | PA
Overview
Corporate Details
- ISIN(s):
- FR0010417345 (+3 more)
- LEI:
- 969500PVBQFWQKVDMD80
- Country:
- France
- Address:
- 107 AVENUE DE LA REPUBLIQUE, 92320 CHATILLON
- Sector:
- Manufacturing
Description
DBV Technologies is a clinical-stage biopharmaceutical company developing treatments for food allergies and other immunological diseases. The company's core technology is Viaskin®, a proprietary investigational platform based on epicutaneous immunotherapy (EPIT). This non-invasive patch technology is designed to re-educate the immune system by delivering minimal amounts of antigens through intact skin. DBV's lead product candidate, Viaskin Peanut (DBV712), is in late-stage clinical development for the treatment of peanut allergies in pediatric patients. The development pipeline also includes Viaskin Milk (DBV135) for milk allergies, with the platform holding potential for applications beyond food allergies.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2023-03-13 06:30 |
Mise à jour DBV Technologies
|
French | 135.1 KB | ||
| 2023-03-13 06:30 |
DBV Technologies Update
|
English | 121.5 KB | ||
| 2023-03-07 22:30 |
DBV Technologies Announces First Patient Screened in VITESSE Phase 3 Clinical T…
|
English | 232.4 KB | ||
| 2023-03-07 22:30 |
DBV Technologies annonce le screening du premier patient de l'essai clinique de…
|
French | 233.7 KB | ||
| 2023-03-02 23:30 |
DBV Technologies announces filing of 2022 Annual Report on Form 10-K and 2022 U…
|
English | 120.0 KB | ||
| 2023-03-02 23:30 |
DBV Technologies publie son « Form 10-K » américain et son Document d’Enregistr…
|
French | 152.6 KB | ||
| 2023-03-02 22:30 |
DBV Technologies Reports Full Year 2022 Financial Results and Business Update
|
English | 213.6 KB | ||
| 2023-03-02 22:30 |
DBV technologies annonce ses résultats financiers pour l’exercice 2022 et fait …
|
French | 237.0 KB | ||
| 2023-03-02 15:30 |
Document d'Enregistrement Universel 2022
|
French | 42.2 MB | ||
| 2023-03-02 15:30 |
Document d'Enregistrement Universel 2022
|
French | 42.2 MB | ||
| 2023-02-27 07:30 |
DBV Technologies to Report Full Year 2022 Financial Results and Business Updat…
|
English | 126.9 KB | ||
| 2023-02-27 07:30 |
DBV Technologies publiera ses résultats financiers pour l’année 2022 et fera l…
|
French | 146.9 KB | ||
| 2023-02-21 22:30 |
DBV Technologies participera au prochain congrès de l’AAAAI 2023
|
French | 185.4 KB | ||
| 2023-02-21 22:30 |
DBV Technologies to Participate in Upcoming AAAAI 2023 Congress
|
English | 159.2 KB | ||
| 2023-02-10 22:30 |
DBV Technologies invitée à participer à une prochaine Conférence Investisseur
|
French | 129.2 KB |
Automate Your Workflow. Get a real-time feed of all DBV Technologies filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for DBV Technologies
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for DBV Technologies via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2022-06-09 | N/A | Other | Other | 2,483,161 | 7,449,483.00 EUR |
Peer Companies
